Генетика адипокинов: Секреторный дисбаланс жировой ткани как основа метаболического синдрома (стр. 5 )

10. Despres J. P. Abdominal obesity as important component of insulin-resistance syndrome // Nutrition. - 1993. – Vol. 9. №. 5. – P. 452-459.

11. Perusse L., Despres J. P., Lemieux S. et al. Familial aggregation of abdominal visceral fat level: results from the Quebec family study // Metabolism. - 1996. – Vol. 45. №. 3. - P. 378-382.

12. Rice T., Perusse L., Bouchard C., Rao D. C. Familial clustering of abdominal visceral fat and total fat mass: the Quebec Family Study // Obes Res. 1996. – Vol. 4. №. 3. - P. 253-261.

13. Vohl M. C., Sladek R., Robitaille J., et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men // Obes. Res. - 2004. – Vol. 12. №. 8. - P. 1217-1222.

14. van Beek E. A., Bakker A. H., Kruyt P. M., et al. Intra - and interindividual variation in gene expression in human adipose tissue // Pflugers Arch. - 2006. – Vol. 453. №. 6. - P. 851-861.

15. Ramis J. M., Franssen-van Hal N. L., Kramer E. et al. Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects // Cell Mol. Life Sci. - 2002. – Vol. 59. №. 11. - P. 1960-1971.

16. van Harmelen V., Dicker A., Ryden M., et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes // Diabetes. - 2002. – Vol. 51. №. 7. - P. 2029-2036.

17. Rankinen T., Zuberi A., Chagnon Y. C. et al. The human obesity gene map: the 2005 update // Obesity (Silver Spring). – 2006. – Vol. 14. №. 4. P. 529-644.

18. Neel J. V. Diabetes mellitus: a ‘thrifty’ genotype rendered detrimental by ‘progress’? // Am. J. Hum. Genet. – 1962. – Vol. 14. – P. 353–362.

19. Crossno J. T. Jr, Majka S. M., Grazia T., et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells // J. Clin. Invest. - 2006. – Vol. 116. №. 12. - P. 3220-3228.

20. Cancello R., Henegar C., Viguerie N., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss // Diabetes. - 2005. – Vol. 54. №. 8. – P. 2277–2286.

21. Skurk T., Herder C., Kraft I., et al. Production and release of macrophage migration inhibitory factor from human adipocytes // Endocrinology. - 2005. – Vol. 146. №. 3. - P. 1006-1011.

22. Permana P. A., Menge C., Reaven P. D. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance // Biochem. Biophys. mun. - 2006. – Vol. 10. №. 2. - P. 507–514.

23. Fain J. N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells // Vitam. Horm. - 2006. – Vol. 74: - P. 443-477.

24. Marra F., Aleffi S., Bertolani C., et al. Adipokines and liver fibrosis // Eur. Rev. Med. Pharmacol. Sci. - 2005. – Vol. 9. №. 5. - P. 279-284.

25. Baranova A., Randhawa M., Jarrar M., Younossi Z. M. Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease // Expert Rev. Mol. Diagn. - 2007. – Vol. 7. №. 2. - P.195-205.

26. Giuliani D., Mioni C., Altavilla D., et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia // Endocrinology. - 2006. – Vol. 147. №. 3. - P. 1126-1135.

27. Versteeg D. H., Van Bergen P., Adan R. A, De Wildt D. J. Melanocortins and cardiovascular regulation // Eur. J. Pharmacol. - 1998. – Vol. 360. №. 1. - P. 1-14.

28. Wang Y., Lam K. S. Chan L., et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex // J. Biol. Chem. - 2006. – Vol. 281. №. 24. - P. 16391-16400.

29. Bobbert T., Rochlitz H., Wegewitz U., et al. Changes of adiponectin oligomer composition by moderate weight reduction // Diabetes. - 2005. – Vol. 54. №. 9. - P. 2712-2719.

30. Rasmussen M. S., Lihn A. S., Pedersen S. B., et al. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots // Obesity (Silver Spring). - 2006. – Vol. 14. №. 1. - P. 28-35.

31. Menzaghi C., Trischitta V., Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease // Diabetes. - 2007. – Vol. 56. №. 5. – P. 1198-1209.

32. Yang W. S., Chuang L. M. Human genetics of adiponectin in the metabolic syndrome // J. Mol. Med. – 2006. – Vol. 84. №. 2. – P. 112-121.

33. Broedl U. C., Lehrke M., Fleischer-Brielmaier E., et al. Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome // Cardiovasc Diabetol. - 2006. – Vol. 5. №. 11. No pages available.

34. Vaxillaire M., Dechaume A., Vasseur-Delannoy V., et al. Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population // Diabetes. - 2006. – Vol. 55. №. 3. - P. 856-861.

35. Mao X., Kikani C. K., Riojas R. A., et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function // Nat. Cell Biol. – 2006. – Vol. 8. №. 5. - P. 516-23.

36. Saito K., Arata S., Hosono T., et al. Adiponectin plays an important role in efficient energy usage under energy shortage // Biochim. Biophys. Acta. - 2006. – Vol. 1761. №. 7. - P. 709-16.

37. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions // Nat. Med. - 2007. – Vol. 13. №. 3. - P. 332-339.

38. Shibata R., Ouchi N., Ito M., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart // Nat. Med. - 2004. – Vol. 10. №. 12. – P. 1384-1389.

39. Kumada M., Kihara S., Ouchi N., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages // Circulation. - 2004. – Vol. 109. №. 17. - P. 2046-2049.

40. Sell H., Dietze-Schroeder D., Eckardt K., Eckel J. Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone // Biochem. Biophys. mun. - 2006. – Vol. 343. №. 3: - P. 700-706.

41. Scherer P. E. Short talk: Novel role of adiponectin in PPARγ Gene Regulation // Keystone Symposia “Metabolic Syndrome and Cardiovascular Risk”, March 27-April 1, 2007, Steamboat Springs, CO, USA.

42. Pagano C., Soardo G., Esposito W., et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease // Eur. J. Endocrinol. - 2005. – Vol. 152. №. 1. - P. 113-118.

43. Kojima S., Funahashi T., Maruyoshi H., et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma // Thromb. Res. - 2005. – Vol. 115. №. 6. – P. 483-490.

44. Chen T. H., Chen L., Hsieh M. S., et al. Evidence for a protective role for adiponectin in osteoarthritis // Biochim Biophys Acta. 2006. – Vol. 1762. №. 8. – P. 711-718.

45. Leo R., Di Lorenzo G., Tesauro M., et al. Decreased plasma adiponectin concentration in major depression // Neurosci. Lett. - 2006. – Vol. 407. №. 3. - P. 211-213.

46. Liu Y. H., Tsai E. M., Wu L. C., et al. Higher basal adiponectin levels are associated with better ovarian response to gonadotropin stimulation during in vitro fertilization // Gynecol. Obstet. Invest. - 2005. – Vol. 60. №. 3. - P. 167-170.

47. Cust A. E., Kaaks, R., Friedenreich C. et al. Plasma adiponectin levels and endometrial cancer risk in pre - and postmenopausal women // J. Clin. Endocrinol. Metab. 2007. – Vol. 92. №. 1. - P. 255-263.

48. Michalakis K., Williams C. J., Mitsiades N., et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study // Cancer Epidemiol. Biomarkers Prev. - 2007. – Vol. 16. №. 2. - P. 308-313.

49. Raguso C., McCullough A. J. Leptin and the gastrointestinal tract // Curr. Opin. Gastroenterol. - 2000. – Vol. 16. №. 2. - P. 160-165.

50. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance // Front. Neuroendocrinol. - 2003. – Vol. 24. №. 4. - P. 225-253.

51. Mark A. L., Correia M. L., Rahmouni K., Haynes W. G. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications // J. Hypertens. - 2002. – Vol. 20. №. 7. - P. 1245-1250.

52. Benomar Y., Wetzler S., Larue-Achagiotis C., et al. In vivo leptin infusion impairs insulin and leptin signalling in liver and hypothalamus // Mol. Cell. Endocrinol. - 2005. – Vol. 242. №. 1-2. – P. 59-66.

53. Jordan J., Brabant G., Brinsuk M. et al. Heritability of free and receptor-bound leptin in normal twins // Am. J. Physiol. Regul. p. Physiol. - 2005 – Vol. 88. №. 5. P. R1411-1416.

54. Liu Y. J., Rocha-Sanchez S. M., Liu P. Y., et al. Tests of linkage and/or association of the LEPR gene polymorphisms with obesity phenotypes in Caucasian nuclear families // Physiol. Genomics. - 2004. – Vol. 17. №. 2. - P. 101-106.

55. Miettinen K. H., Magga J., Vuolteenaho O., et al. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy // Regul. Pept. - 2007. – Vol. 140. №. 3. - P. 178-184.

56. de Krom M., van der Schouw, Y. T., Hendriks J., et al. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns // Diabetes. - 2007. – Vol. 56. №. 1. - P. 2762-80.

57. Gaukrodger N., Mayosi B. M., Imrie H., et al. A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families // J. Med. Genet. - 2005. – Vol. 42. №. 6. - P. 474-478.